Categories: News

Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th

Dallas, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2025 financial results on Thursday, February 26th, 2026 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. The live webcast and a presentation related to the call will be accessible from the “Investors” section of Enovis’ website at www.enovis.com.

Conference Call/Webcast Information

Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.

About Enovis

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.

Availability of Information on the Enovis Website

Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares on ir.enovis.com.

Kyle Rose
Vice President, Investor Relations
Enovis Corporation
investorrelations@enovis.com

Staff

Recent Posts

PROCOMER leads Costa Rica’s largest-ever business delegation to MD&M West 2026

Connecting talent, innovation, and business opportunities in the medical devices sector is the main objective…

8 hours ago

PROCOMER leads Costa Rica’s largest-ever business delegation to MD&M West 2026

Connecting talent, innovation, and business opportunities in the medical devices sector is the main objective…

8 hours ago

AltaPointe Health Launches Weekly Online Veteran Peer Support Group

MOBILE, Ala., Jan. 23, 2026 /PRNewswire/ -- AltaPointe Health is launching a new weekly online…

8 hours ago

AltaPointe Health Launches Weekly Online Veteran Peer Support Group

MOBILE, Ala., Jan. 23, 2026 /PRNewswire/ -- AltaPointe Health is launching a new weekly online…

8 hours ago

Consciousness Has No Limits: Small Healer Groups Override Random Devices Globally – Just by Meditating

Peer-reviewed research by Dr Joe Dispenza and HeartMath Institute reveals measurable global effects of emotionally coherent…

14 hours ago

Consciousness Has No Limits: Small Healer Groups Override Random Devices Globally – Just by Meditating

Peer-reviewed research by Dr Joe Dispenza and HeartMath Institute reveals measurable global effects of emotionally coherent…

14 hours ago